Table 1.

Clinical features of the seven patients with COVID-19 and controls.

Patients	Sample	Sex	Age	Coexisting disease	Disease type when enrolled	Disease type when discharged	Antiviral therapy	Immunoglobulin therapy	Glucocorticoid therapy	Mechanical ventilation	ARDS when sampled	ARDS during whole disease period	ICU admission	Clinical outcome	Days from symptom onset
Patient 1	S1	Male	59	No	Severe	Severe	Yes	Yes	Yes	No	Yes	Yes	No	Discharged home	7
Patient 2	S2	Female	66	Hypertension	Critical	Critical	Yes	No	Yes	Yes	Yes	Yes	Yes	Discharged home	18
	R7
Patient 3	S3	Male	53	Hypertension	Severe	Severe	Yes	No	Yes	No	Yes	Yes	No	Discharged home	13
	R3														30
Patient 4	M1	Female	59	Fatty liver	Moderate	Moderate	Yes	No	No	No	No	No	No	Discharged home	6
	R1														24
	R6														31
Patient 5	M2	Female	48	Fatty liver	Moderate	Severe	Yes	No	Yes	No	No	Yes (4 days after sampled)	No	Discharged home	6
Patient 6	M3	Male	66	No	Moderate	Moderate	Yes	No	No	No	No	No	No	Discharged home	13
	R4														25
	R5														32
Patient 7	M4	Male	62	Hepatitis B	Moderate	Moderate	Yes	No	No	No	No	No	No	Discharged home	3
	R2														25
Control 1	N1	Female	55	No
Control 2	N2	Female	51	No
Control 3	N3	Female	54	No
Control 4	N4	Male	55	No
Control 5	N5	Male	61	No
Control 6	N6	Male	58	No

S1–3: the severely infected or critically ill group; M1–4: the moderate group; R1–7: the convalescent/recovery group; N1–6: the control/normal group. ARDS: acute respiratory distress syndrome; ICU: intensive care unit.